Jordi Cano, Esther Zorio, Esther Zorio, Andrea Mazzanti, Andrea Mazzanti, Miguel Ángel Arnau, . . . Lucia Romero. (2020). Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJordi Cano, et al. Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. Frontiers Media S.A., 2020.
MLA (9th ed.) CitationJordi Cano, et al. Ranolazine as an Alternative Therapy to Flecainide for SCN5A V411M Long QT Syndrome Type 3 Patients. Frontiers Media S.A., 2020.
Warning: These citations may not always be 100% accurate.